IZI

VEON launches ROX, its digital-first brand in Pakistan

Retrieved on: 
Tuesday, February 27, 2024
OQ, Tamasha, Maus, GameNOW, Euronext Amsterdam, ROX, IZI, VEON

MWC24 Barcelona, 27 February 2024: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, announces that Jazz, its digital operator in Pakistan, is launching ROX, a new mobile service brand to serve the digital natives of the country with an integrated lifestyle experience.

Key Points: 
  • MWC24 Barcelona, 27 February 2024: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, announces that Jazz, its digital operator in Pakistan, is launching ROX, a new mobile service brand to serve the digital natives of the country with an integrated lifestyle experience.
  • ROX is designed to appeal to the digital-first generation of Pakistan and provides a range of digital lifestyle services through a dedicated mobile app.
  • "In Pakistan, with 64% of the population under the age of 30, there is a significant demand for digital-first experiences.
  • In Uzbekistan, the OQ was launched in October 2023 and had already gained 177 thousand MAUs by December 31st.

Affimed Presents Preclinical Data Showing that Addition of an Innate Cell Engager to NK and CAR-NK Cells Improves Tumor Cytotoxicity of Both Cell Types at the 38th Annual Meeting of the Society for Immunotherapy of Cancer

Retrieved on: 
Friday, November 3, 2023
IZI, Society for Immunotherapy of Cancer, Affimer, Engineering, Poster, SITC, Immunotherapy, ADCC, NK, Cell therapy, Society, Cancer, Patient, Fraunhofer Society, Fertilizer, Vaccine

“This is the first direct comparison of NK cells redirected by Affimed’s ICE® with CAR-NK cells,” said Dr. Arndt Schottelius, Chief Scientific Officer at Affimed.

Key Points: 
  • “This is the first direct comparison of NK cells redirected by Affimed’s ICE® with CAR-NK cells,” said Dr. Arndt Schottelius, Chief Scientific Officer at Affimed.
  • The combination of allogeneic NK cells with ICE® molecules represents the most straightforward way to generate potent and targeted NK cells.
  • The combination of the ICE® molecule with NK cells or CAR-NK cells enhanced antibody-dependent cellular cytotoxicity (ADCC) against tumor cells and mediated elevated levels of degranulation when compared to NK cells or CAR-NK cells alone.
  • In conclusion, the combination of NK cells with ICE® represents a straight-forward way to potently target and activate NK cells.